Name: Black Diamond Therapeutics, Inc. (BDTX) Balance Sheet
Creator: FinSpry

Black Diamond Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Black Diamond Therapeutics, Inc. (BDTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	36.44	56.22	34.32	209.79	34.61	154.67
Short-Term Investments	62.14	75.18	88.49	143.99	280.46	0.00
Cash & Short-Term Investments	98.58	131.40	122.81	209.79	315.07	154.67
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.60	2.63	4.90	5.92	4.49	0.00
Total Current Assets	101.18	134.03	127.71	215.70	319.55	155.71
Non-Current Assets
Property, Plant & Equipment (Net)	20.40	23.71	27.38	30.74	8.79	0.16
Other Non-Current Assets	1.07	0.82	1.17	1.24	1.33	0.11
Total Non-Current Assets	21.46	24.53	28.55	31.98	10.12	2.58
Total Assets	122.64	158.57	156.26	247.68	329.67	158.30
Current Liabilities
Accounts Payable	4.01	2.32	1.88	23.64	2.54	4.86
Short-Term Debt	3.40	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	13.16	14.21	10.54	19.22	10.63	0.00
Other Current Liabilities	13.16	5.18	4.65	5.09	3.73	0.02
Total Current Liabilities	20.57	19.65	15.26	23.64	14.22	4.86
Non-Current Liabilities
Long-Term Debt	18.78	22.19	25.30	28.14	7.69	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	18.78	22.19	25.30	28.14	7.69	200.59
Total Liabilities	39.36	41.83	40.56	51.78	21.91	205.45
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-487.11	-417.43	-334.99	-244.23	-118.22	-50.97
Accumulated Other Comprehensive Income	0.02	-0.03	-1.82	-0.41	0.61	0.00
Additional Paid-in Capital	570.36	534.19	452.50	440.13	425.36	3.81
Shares Outstanding	56.64	51.65	36.43	36.23	0.00	0.00
Total Stockholders' Equity	83.29	116.74	115.70	195.90	307.76	-47.16
Total Liabilities & Equity	122.64	158.57	156.26	247.68	329.67	158.30